Press Resease

Clinical Risk Grouping Solutions Market - Global Industry Analysis

Clinical Risk Grouping Solutions Market: by Product (Dashboard Analytics Solutions, Scorecards & Visualization Tools, and Risk Reporting Solutions); by Deployment Mode (Public Cloud, Private Cloud, and Hybrid Cloud), for Payers, Hospitals, Long-Term Care Centers, Ambulatory Care Centers and Other End Users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Published Date: 16-Oct-2019 Category: Healthcare Report Format : PDF Pages: 126 Report Code: ZMR-4864 Status : Published

According to the report, global demand for clinical risk grouping solutions market was valued at approximately USD 391.5 million in 2018, and is expected to generate revenue of around USD 907.1 million by end of 2025, growing at a CAGR of around 12.8% between 2019 and 2025.

Description

The report covers forecast and analysis for the clinical risk grouping solutions market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the clinical risk grouping solutions market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the clinical risk grouping solutions market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the clinical risk grouping solutions market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the clinical risk grouping solutions market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the clinical risk grouping solutions market on global and regional basis.

Clinical Risk Grouping Solutions Market

The study provides a crucial view on the clinical risk grouping solutions by segmenting the market based on deployment mode, product, end user and region. All the segments of clinical risk grouping solutions market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Clinical risk grouping (CRG) solution is a population classification system used which uses ambulatory and inpatient diagnosis and procedure codes, functional health status and pharmaceutical data to allocate each individual to a unique or single, severity-adjusted group. Clinical risk group is a categorical classification system based on clinical evidence and uses administrative data to recognize adults and children with chronic health conditions. Clinical risk grouping software uses proficient clinical logic to allocate each individual to a particular risk group. Clinical risk groups are used to profile physician practice patterns, health service utilization patterns, track chronic or congenital disease prevalence, risk adjustment for pricing and capitation, etc.

Clinical risk grouping solutions are gaining momentum in the market owing to their advantages, growing need for risk management to offer better patient care, reduce errors and increasing use of big data solutions. However, lack of infrastructure, data privacy issues, dearth of trained health care IT workers are factors that may hamper the growth of this market. Increasing focus of healthcare solution providers on use of artificial intelligence and machine learning are expected to bring new growth avenues for clinical risk grouping solutions market.

Based on product, global clinical risk grouping solutions market is bifurcated into dashboard analytics solutions, scorecards & visualization tools, and risk reporting solutions. The scorecards & visualization tools segment accounted for largest market share in 2018 as a result of increasing need for patient precision and forecast risks. The dashboard analytics solutions segment is expected to grow at a highest CAGR over the forecast period. Increasing acceptance of risk reporting solutions is expected drive the demand for risk reporting solutions segment during the forecast period.

Based on deployment mode global clinical risk grouping solutions market is segmented into public cloud, hybrid cloud and private cloud. High data security offered by private cloud drive the demand for private cloud deployment mode. On the other hand, cost effectiveness of public cloud over private cloud is driving its demand. Growth of the hybrid cloud segment is driven by its flexibility and ability to avoid vendor lock-in.

The end user segment is divided into payers, hospitals, long term care centers, ambulatory care centers and others. Hospitals end user segment held largest market share in 2018 whereas payers will adopt the clinical risk grouping solution at faster growth rate over the forecast period.

The current and estimated demand for regions such as Middle East & Africa, North America, Asia Pacific, Latin America and Europe is covered for clinical risk grouping solutions market. North America held largest market share of global clinical risk grouping solutions market. Increasing government initiatives on management of population health, favorable regulatory framework, presence major solution providers and need to reduce errors in patient care drive the demand for clinical risk grouping solutions in North America. Asia Pacific region will witness highest CAGR over the forecast period owing to increasing population and demand for better healthcare services. Europe was second largest regional market in 2018. Growth in Europe is driven by government initiatives to promote use of healthcare IT solutions to reduce cost, time and errors. Latin America and Middle East Africa regions will register considerable growth during the forecast period.

Major players included in the report are 3M, Conduent Inc., Cerner Corporation, Nuance Communications, HBI Solutions, Health Catalyst, Lightbeam Health Solutions, Johns Hopkins University, 4S Information Systems, Dynamic Healthcare Systems, PeraHealth, and Evolent Health.

The report segment of global clinical risk grouping solutions market as follows:

Global Clinical Risk Grouping Solutions Market: By Product

  • Scorecards & Visualization Tools
  • Dashboard Analytics Solutions
  • Risk Reporting Solutions

Global Clinical Risk Grouping Solutions Market: By Deployment Mode

  • Private Cloud
  • Public Cloud
  • Hybrid Cloud

Global Clinical Risk Grouping Solutions Market: End User Analysis

  • Hospitals
  • Payers
  • Ambulatory Care Centers
  • Long-Term Care Centers
  • Other End Users

Global Clinical Risk Grouping Solutions Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Clinical Risk Grouping Solutions Market, 2016-2025 (USD Million)
    • 2.2. Clinical Risk Grouping Solutions Market, 2016-2025 (USD Million)
    • 2.3. Clinical Risk Grouping Solutions Market: Snapshot
  • Chapter 3. Clinical Risk Grouping Solutions Market - Industry Analysis
    • 3.1. Clinical Risk Grouping Solutions Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness analysis By Deployment Mode
      • 3.6.3. Market attractiveness analysis By End User Analysis
      • 3.6.4. Market attractiveness analysis by Region
  • Chapter 4. Clinical Risk Grouping Solutions Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Clinical Risk Grouping Solutions Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Clinical Risk Grouping Solutions Market -Product Analysis
    • 5.1. Global Clinical Risk Grouping Solutions Market overview: By Product type
      • 5.1.1. Global Clinical Risk Grouping Solutions Market share, By Product,2018 and 2025
    • 5.2. Scorecards & Visualization Tools
      • 5.2.1. Global Clinical Risk Grouping Solutions Market by Scorecards & Visualization Tools, 2016-2025 (USD Million)
    • 5.3. Dashboard Analytics Solutions
      • 5.3.1. Global Clinical Risk Grouping Solutions Market by Dashboard Analytics Solutions, 2016-2025 (USD Million)
    • 5.4. Risk Reporting Solutions
      • 5.4.1. Global Clinical Risk Grouping Solutions Market by Risk Reporting Solutions, 2016-2025 (USD Million)
  • Chapter 6. Global Clinical Risk Grouping Solutions Market -Deployment Mode Analysis
    • 6.1. Global Clinical Risk Grouping Solutions Market overview: By Deployment Mode
      • 6.1.1. Global Clinical Risk Grouping Solutions Market share, By Deployment Mode, 2018 and 2025
    • 6.2. Private Cloud
      • 6.2.1. Global Clinical Risk Grouping Solutions Market By Private Cloud, 2016-2025 (USD Million)
    • 6.3. Public Cloud
      • 6.3.1. Global Clinical Risk Grouping Solutions Market By Public Cloud, 2016-2025 (USD Million)
    • 6.4. Hybrid Cloud
      • 6.4.1. Global Clinical Risk Grouping Solutions Market By Hybrid Cloud, 2016-2025 (USD Million)
  • Chapter 7. Global Clinical Risk Grouping Solutions Market -End User Analysis Analysis
    • 7.1. Global Clinical Risk Grouping Solutions Market overview: By End User Analysis
      • 7.1.1. Global Clinical Risk Grouping Solutions Market share, By End User Analysis, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global Clinical Risk Grouping Solutions Market by Hospitals, 2016-2025 (USD Million)
    • 7.3. Payers
      • 7.3.1. Global Clinical Risk Grouping Solutions Market by Payers, 2016-2025 (USD Million)
    • 7.4. Ambulatory Care Centers
      • 7.4.1. Global Clinical Risk Grouping Solutions Market by Ambulatory Care Centers, 2016-2025 (USD Million)
    • 7.5. Long-Term Care Centers
      • 7.5.1. Global Clinical Risk Grouping Solutions Market by others, 2016-2025 (USD Million)
    • 7.6. Others
      • 7.6.1. Global Clinical Risk Grouping Solutions Market by others, 2016-2025 (USD Million)
  • Chapter 8. Global Clinical Risk Grouping Solutions Market - Regional Analysis
    • 8.1. Global Clinical Risk Grouping Solutions Market overview: by Region
      • 8.1.1. Global Clinical Risk Grouping Solutions Marketshare, by Region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Clinical Risk Grouping Solutions Market, 2016-2025 (USD Million)
      • 8.2.2. North America Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
      • 8.2.3. North America Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
      • 8.2.4. North America Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S.Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.5.2. The U.S.Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.2.5.3. The U.S.Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.6.2. Rest of North America Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.2.6.3. Rest of North America Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Clinical Risk Grouping Solutions Market, 2016-2025 (USD Million)
      • 8.3.2. Europe Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
      • 8.3.3. Europe Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
      • 8.3.4. Europe Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. U.K.Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.5.2. U.K.Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.3.5.3. U.K. Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.6.2. France Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.3.6.3. France Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.7.2. Germany Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.3.7.3. Germany Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of EuropeClinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.8.2. Rest of EuropeClinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.3.8.3. Rest of Europe Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Clinical Risk Grouping Solutions Market, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
      • 8.4.3. Asia Pacific Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
      • 8.4.4. Asia Pacific Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.5.2. China Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.4.5.3. China Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.6.2. Japan Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.4.6.3. Japan Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.7.2. India Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.4.7.3. India Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Clinical Risk Grouping Solutions Market, 2016-2025 (USD Million)
      • 8.5.2. Latin America Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
      • 8.5.3. Latin America Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
      • 8.5.4. Latin America Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.5.5.2. Brazil Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.5.5.3. Brazil Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
      • 8.5.6. Rest of LatinAmerica
        • 8.5.6.1. Rest of LatinAmerica Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
        • 8.5.6.2. Rest of LatinAmerica Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
        • 8.5.6.3. Rest of Latin America Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Clinical Risk Grouping Solutions Market, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Clinical Risk Grouping Solutions Market revenue, By Product,2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Clinical Risk Grouping Solutions Market revenue, By Deployment Mode, 2016-2025 (USD Million)
      • 8.6.4. The Middle East and Africa Clinical Risk Grouping Solutions Market revenue, By End User Analysis, 2016-2025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. 3M
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Conduent Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Cerner Corporation
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Nuance Communications
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. HBI Solutions
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Health Catalyst
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Lightbeam Health Solutions
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Johns Hopkins University
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. 4S Information Systems
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. Dynamic Healthcare Systems
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social